Company Page
EnteroBiotix
Founders
EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics for patients with serious unmet medical needs. Founded in 2017 in Glasgow, Scotland, the company harnesses bacterial communities derived directly from the human gastrointestinal tract to prevent and treat diseases including IBS, liver cirrhosis, and blood cancer. It operates MHRA-licensed GMP pharmaceutical manufacturing sites in Glasgow and Aberdeen, and holds a strategic research partnership with Imperial College London.
Company Founded in 2017
